000 | 01645 a2200469 4500 | ||
---|---|---|---|
005 | 20250514200829.0 | ||
264 | 0 | _c20050204 | |
008 | 200502s 0 0 eng d | ||
022 | _a0387-7604 | ||
024 | 7 |
_a10.1016/j.braindev.2003.12.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMori, Masato | |
245 | 0 | 0 |
_aDichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS. _h[electronic resource] |
260 |
_bBrain & development _cOct 2004 |
||
300 |
_a453-8 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAbdominal Pain _xdrug therapy |
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDichloroacetic Acid _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHeadache _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypocalcemia _xchemically induced |
650 | 0 | 4 |
_aLactic Acid _xblood |
650 | 0 | 4 |
_aMELAS Syndrome _xblood |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 |
_aMuscle Weakness _xdrug therapy |
650 | 0 | 4 |
_aPeripheral Nervous System Diseases _xchemically induced |
650 | 0 | 4 |
_aPyruvic Acid _xblood |
650 | 0 | 4 |
_aStroke _xdrug therapy |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aYamagata, Takanori | |
700 | 1 | _aGoto, Tamako | |
700 | 1 | _aSaito, Shigeko | |
700 | 1 | _aMomoi, Mariko Y | |
773 | 0 |
_tBrain & development _gvol. 26 _gno. 7 _gp. 453-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.braindev.2003.12.009 _zAvailable from publisher's website |
999 |
_c15046686 _d15046686 |